GENINUS Inc. (KOSDAQ:389030)
South Korea
· Delayed Price · Currency is KRW 4,225.00
+725.00 (20.71%)
At close: Mar 6, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 140.91 billion as of March 6, 2026. Its market cap has increased by 205.05% in one year.
Market Cap
140.91B
Enterprise Value
135.57B
Revenue
8.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,225.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 140.91B, a decrease of -3.25%. That is a compound annual growth rate of -0.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 140.91B | 20.71% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytogen | 112.46B |
| HLB Panagene | 92.99B |
| Green Cross Medical Science | 79.03B |
| Protia | 64.90B |
| Seoulin Bioscience | 56.23B |
| Dx & Vx | 401.10B |
| 3billion | 437.36B |
| GeneMatrix | 45.27B |